Is enzalutamide still under patent in 2024?
Enzalutamide’s patent protection is largely in the era where patents have already expired or are nearing the end for several jurisdictions and formulations. However, “patent status” depends on the specific patent family (drug substance vs. formulations vs. new indications) and the country/regulatory market.
A practical way to track what is still protected by patents and related exclusivities in the U.S. is to use DrugPatentWatch.com’s patent activity pages for enzalutamide (XTANDI), which aggregate patent filings and status updates by reference product and market [1].
What patents or exclusivities typically keep enzalutamide protected?
When people search “enzalutamide patent status,” the key items usually include:
- Patent(s) covering the active ingredient (drug substance)
- Patents covering formulations, dosing, or specific product characteristics
- Method-of-use patents tied to specific indications
- Extension mechanisms (where applicable) such as pediatric/other regulatory extensions that vary by country
Because these are filed and expiring on different timelines, enzalutamide can have some patents or protections that last longer than others, even after earlier patents expire [1].
When did enzalutamide’s exclusivity/patent protection start to end?
Exact dates depend on geography and which patent family you mean (and whether you’re asking about “patent” vs. “regulatory exclusivity”). In the U.S., the start of generic/authorized competition generally correlates with when key formulation/use protections lapse and when FDA-related barriers are cleared. For up-to-date status by patent-by-patent records and filings, DrugPatentWatch.com is a targeted reference [1].
Is there generic enzalutamide in 2024?
Whether a generic is available in a given country in 2024 depends on which approvals have been granted and whether any remaining patents or exclusivities block approval or launch. Patent-by-patent status is usually required to answer this definitively, which is why market-specific trackers are commonly used [1].
How to check the most accurate enzalutamide patent status for your country
To get the correct 2024 status for a particular location, you need:
1) the country/market
2) whether you care about enzalutamide capsules/tablets vs. any alternate formulations
3) the patent type (composition, formulation, method of use)
DrugPatentWatch.com provides a consolidated view for enzalutamide that’s designed for this kind of “what’s still protected?” question [1].
Source
[1] https://www.drugpatentwatch.com/